These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 944400)

  • 1. Amino acid abnormalities in cerebrospinal fluid of patients with parkinsonism and extrapyramidal disorders.
    Lakke JP; Teelken AW
    Neurology; 1976 May; 26(5):489-93. PubMed ID: 944400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid choline in extrapyramidal disorders.
    Aquilonius SM; Nyström B; Schuberth J; Sundwall A
    J Neurol Neurosurg Psychiatry; 1972 Oct; 35(5):720-5. PubMed ID: 4263743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid amino acids in extrapyramidal disorders before and after L-DOPA treatment.
    Van Sande M; Caers J; Lowenthal A
    Z Neurol; 1971 Apr; 199(1):24-9. PubMed ID: 4102746
    [No Abstract]   [Full Text] [Related]  

  • 4. Amino acid abnormalities in cerebrospinal fluid and blood serum of patients with Parkinson's disease, other heredodegenerative disorders and head injuries.
    Lakke JP; Teelken AW; vd Voet H; Wolthers BG
    Adv Neurol; 1987; 45():243-7. PubMed ID: 3825697
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes in the concentration of amino acids in serum and cerebrospinal fluid of patients with Parkinson's disease.
    Mally J; Szalai G; Stone TW
    J Neurol Sci; 1997 Oct; 151(2):159-62. PubMed ID: 9349670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free amino acids in the cerebrospinal fluid in old age and in Parkinson's disease.
    Gjessing LR; Gjesdahl P; Dietrichson P; Presthus J
    Eur Neurol; 1974; 12(1):33-7. PubMed ID: 4413508
    [No Abstract]   [Full Text] [Related]  

  • 7. [HVA and 5-HIAA in the cerebrospinal fluid in extrapyramidal and cerebrellar syndromes. Preliminary data].
    Carrieri P; Mandarini A; Campanella G
    Acta Neurol (Napoli); 1975; 30(5):449-54. PubMed ID: 132845
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of the administration of amino acids, especially of L-dopa and alpha-methyldopa, on the composition of cerebrospinal fluid in extrapyramidal syndromes. II. Alterations of cerebrospinal fluid in patients with Parkinson's disease and chorea following the administration of alpha-methyldopa].
    Gründig E; Gerstenbrand F; Bruck J; Gnad H; Prosenz P; Simanyi M
    Dtsch Z Nervenheilkd; 1969; 196(3):256-65. PubMed ID: 5820717
    [No Abstract]   [Full Text] [Related]  

  • 9. Alteration of amino acids in cerebrospinal fluid from patients with Parkinson's disease and spinocerebellar degeneration.
    Araki K; Takino T; Ida S; Kuriyama K
    Acta Neurol Scand; 1986 Feb; 73(2):105-10. PubMed ID: 3705920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's disease.
    Engelborghs S; Marescau B; De Deyn PP
    Neurochem Res; 2003 Aug; 28(8):1145-50. PubMed ID: 12834252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ventricular somatostatin-like immunoreactivity in patients with basal ganglia disease.
    Cramer H; Wolf A; Rissler K; Weigel K; Ostertag C
    J Neurol; 1985; 232(4):219-22. PubMed ID: 2864402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Free amino acids in blood and cerebrospinal fluid in Parkinson's disease].
    TORRE M; SCARZELLA R; ZANALDA A
    Minerva Med; 1953 Jul; 44(59-60):256. PubMed ID: 13110848
    [No Abstract]   [Full Text] [Related]  

  • 13. Decreased cerebrospinal fluid levels of neutral and basic amino acids in patients with Parkinson's disease.
    Molina JA; Jiménez-Jiménez FJ; Gomez P; Vargas C; Navarro JA; Ortí-Pareja M; Gasalla T; Benito-León J; Bermejo F; Arenas J
    J Neurol Sci; 1997 Sep; 150(2):123-7. PubMed ID: 9268238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A significant reduction of putative transmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease and spinocerebellar degeneration.
    Tohgi H; Abe T; Hashiguchi K; Takahashi S; Nozaki Y; Kikuchi T
    Neurosci Lett; 1991 May; 126(2):155-8. PubMed ID: 1681472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular cerebrospinal fluid concentrations of putative amino acid transmitters in Parkinson's disease and other disorders.
    Perschak H; Amsler U; Vischer A; Siegfried J; Cuénod M
    Hum Neurobiol; 1987; 6(3):191-4. PubMed ID: 2896652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes].
    Buscaino GA; Mandarini A; Campanella G; Carrieri P; Orefice G
    Acta Neurol (Napoli); 1976; 31(5):565-70. PubMed ID: 138340
    [No Abstract]   [Full Text] [Related]  

  • 17. Cerebrospinal fluid neuraminic acid in parkinsonism and schizophrenia.
    PAPADOPOULOS NM; McLANE JE; O'DOHERTY D; HESS WC
    J Nerv Ment Dis; 1959 May; 128(5):450-2. PubMed ID: 13665366
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of neurotransmitter metabolites and adenosine 3',5'-monophosphate in the CSF of patients with extrapyramidal motor disorders.
    Cramer H; Warter JM; Renaud B
    Adv Neurol; 1984; 40():431-5. PubMed ID: 6198888
    [No Abstract]   [Full Text] [Related]  

  • 19. [Analysis of amino acids in the cerebrospinal fluid].
    Mashiko N
    Nihon Rinsho; 1973 May; 31(5):1029-37. PubMed ID: 4738411
    [No Abstract]   [Full Text] [Related]  

  • 20. CSF choline levels in groups of patients with cranial trauma or extrapyramidal disorders.
    Flentge F; Hajonides-van Der Meulen WM; Lakke JP; Teelken AW
    J Neurol Neurosurg Psychiatry; 1984 Feb; 47(2):207-9. PubMed ID: 6707661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.